Radiopharmaceuticals in sentinel lymph-node detection - An overview

European Journal of Nuclear Medicine

Volumn 26, Issue SUPPL., 1999, Pages

  Wilhelm, Abraham J ^a   Mijnhout, G Sophie ^a   Franssen, Eric J F ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

99mTc antimony trisulfide colloid; 99mTc colloidal albumin; 99mTc sulfur colloid; Radiocolloids; Sentinel node

Indexed keywords

ALBUMIN TC 99M; ANTIMONY TECHNETIUM SULFIDE TC 99M; GOLD 198; RADIOPHARMACEUTICAL AGENT; TECHNETIUM SULFUR COLLOID TC 99M;

BREAST CANCER; CANCER STAGING; CONFERENCE PAPER; DRUG ABSORPTION; DRUG HALF LIFE; DRUG UPTAKE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MELANOMA; REGIONAL PERFUSION; SUBCUTANEOUS DRUG ADMINISTRATION;

GOLD RADIOISOTOPES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; RADIOPHARMACEUTICALS; SODIUM PERTECHNETATE TC 99M;

EID: 0032929289     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050576     Document Type: Conference Paper

References (50)

1. Bennert LR, Lago G. Cutaneous lymphoscintigraphy in malignant melanoma. Semin Nucl Med 1983; 13: 61-69.
2. Sadek S, Owunwanne A, Abdel-Dayem HM, Yacoub T. Preparation and evaluation of Tc-99m hydroxy-ethyl starch as a potent radiopharmaceutical for lymphoscintigraphy: comparison with Tc-99m human serum albumin. Lymphology 1989; 22: 844.
3. Lamki LM, Haynie TP, Balch CM, Bhadkamkar VA. Podoloff DA, Kim EE. Lymphoscintigraphy in the surgical management of patient with truncal melanoma: comparison of technetium sulfur with technetium human serum albumin [abstract]. J Nucl Med 1989; 30: 844.
4. McNeill GC, Witte M II, Witte CL, et al. Whole-body lymphoscintigraphy: preferred method for initial assessment of the peripheral lymphatic system. Radiology 1989; 172: 495-502.
5. Kataoka M, Kawamura M, Hamada K, Itoh H, Nishiyama Y, Hamamoto K. Quantitative lymphoscintigraphy using 99mTc human serum albumin in patients with previously treated uterine cancer. Br J Radiology 1991 ; 64; 1119-1121.
6. Fee HJ, Robinson DS. Sample WF, Graham LS, Holmes EC, Morton DL. The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study. Surgery 1978; 84: 626-632.
7. Alavi A, Staum MM, Shesol BF, Bloch PH. Technetium 99m stannous phytate as an imaging agent for lymph nodes. J Nucl Med 1978; 19: 422-426.
8. Hung JC, Wiseman GA, Wahner HW, Mullan BP, Taggart TR, Dunn WL. Filtered technetium-99m sulfur colloid evaluated for lymphoscintigraphy. J Nucl Med 1995; 36: 1895-1901.
9. Strand S-E, Persson B. Quantitative lymphoscintigraphy. 1 Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med 1979; 20: 1038-1046.
10. Alazraki NP, Eshima D, Eshima LA, et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med 1997; 27: 55-67.
11. Saha GP, Feiglin DHI, O'Donnell JK. Go RT, Karam PM, Maclntyre W. Experience with technetium-99m albumin colloid kit for reticuloendothelial system imaging. J Nucl Med Technol 1986; 14: 149-151.
12. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EFI, Boom RPA, van Diest PJ, Teule GJJ. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997; 38: 366-368.
13. Ikomi F, Hanna GK, Schmidt-Schonbein GW. Mechanism of colloid uptake into the lymphatic system: basic study with percutaneous lymphography. Radiology 1995; 196: 107-113.
14. Bergqvist L, Strand S-E, Persson B. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. Semin Nucl Med 1983; 12: 9-19.
15. Ege GN. Internal mammary lymphoscintigraphy. Radiology 1976; 118: 101-107.
16. Henze E, Scheibert HR, Collins JD, et al. Lymphoscintigraphy with 99mTc-labeled dextran. J Nucl Med 1982; 23: 923-929.
17. Jager PL, Doting MHE, Jansen L, et al. Sentinel node localization in breast cancer [abstract]. Eur J Nucl Med 1998; 25: 838.
18. Albertini JJ, Lyman GB, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276: 1818-1822.
19. Borgstein PJ, Pijpers R, Comans EF, Diest PJ van, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-283.
20. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998; 339: 941-946.
21. Paganelli G, De Cicco C, Cremonesi M, Prisco G, Calza P, Luini A, Zucali A, Veronesi U. Optimized sentinel node scintigraphy. Q J Nucl Med 1998; 42: 49-53.
22. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-867.
23. Uren R, Commens C, Howman-Giles R. Intradermal injections: a potential health hazard?. Med J Australia 1994; 161: 226.
24. Eshima D, Eshima LA, Gotti NM, Herda SC, Algozine CA, Burris TG, Vansant JP, Alazraki NP, Taylor AT. Technetium-99m-sulfur colloid for lymphoscintigraphy: effects of preparation parameters. J Nucl Med 1996; 37: 1575-1578.
25. Dragotakes SC, Callahan RJ, LaPointe LC et al. Particle characterization of a filtered 99m-Tc-sulfur colloid preparation for lymphoscintigraphy/ (abstract). J Nucl Med 1995; 36 (Suppl): 80.
26. Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med 1998; 39: 1185-1190.
27. Pijpers R, Borgstein PJ, Meijer S, Krag DN, Hoekstra OS, Greuter HNJM, Teule GJJ. Transport and retention of colloidal tracers in regional lymphoscintigraphy in melanoma: influence on lymphatic mapping and sentinel node biopsy. Melanoma Res 1998; 8: 413-418.
28. Mudun A, Murray DR, Herda SC, et al. Early stage melanoma: lymphoscintigraphy. reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe. Radiology 1996; 199: 171-175.
29. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for paticnts with melanoma. Ann Surg 1996; 223: 217-224.
30. Smith EM, Smoak WM, Gilson AJ. Letter to the editor. J Nucl Med 1967; 8: 896-898.
31. Amersham Cygne. ALBU-RES (kit for the preparation of technetium Tc-99m microcolloidal albumin) summary of the product characteristics. Eindhoven, The Netherlands. February. 1996.
32. Amersham Cygne. Solco NANOCOLL (kit for the preparation of technetium Tc-99m nunocolloidal albumin) summary of the product characteristics. Eindhoven. The Netherlands. December. 1996.
33. Pijpers R, Borgstein PJ, Meijer S, Hoekstra AS, van Hattum LH, Teule GJJ. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 1997; 21: 788-793.
34. Kapteijn BAE, Nieweg OE, Valdés Olmos RA, Liem IH, Baidjnath Panday RKL, Hoefnagel CA, Kroon BBR. Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med 1996; 37: 972-975.
35. Kapteijn BAE, Nieweg OE, Muller SH, Liem IH, Hoefnagel CA, Rutgers EJTh, Kroon BBR. Validation of gamma probe detection of the sentinel node in melanoma. J Nucl Med 1997; 38: 362-366.
36. Steigman J, Eckelman WC, Chapter IV. Technetium (VII) compounds, in: the Chemistry of technetium in medicine. National Academy Press. Washington DC.
37. Bergqvist L, Strand S-E, Persson B, Hafstrom L, Johnsson P-E. Dosimetry in lymphoscintigraphy of Tc-99m antimony sulfide colloid. J Nucl Med 1982; 23: 698-705.
38. Uren RF, Hofman-Giles RB, Shaw HM, Thompson JF, McCarthy WH. Lymphoscintigraphy in high risk melanoma of the trunk: predicting drainage node groups, defining lymphatic channels, and locating the sentinel node. J Nucl Med 34; 1435-1440.
39. O'Brien CJ, Uren RF, Thompson JF Howman-Giles RB. Petersen-Schaefer K, Shaw HM, Quinn MJ, McCarthy WH. Prediction of potential metustatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995; 170: 461-466.
40. Uren RF, Howman-Giles RB, Thompson JF, Malouf D. Ramsey-Stewart G, Niesche FW, Renwick SB. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995; 36: 1775-1780.
41. Keeling DH, Sampson CB. Adverse reactions to radiopharmaceuticals: incidence. reporting, symptoms, treatment. Nuklearmedizin [Suppl| 1987; 23: 478-482.
42. Ponto JA. Adverse reactions to technelium-99m colloids [Letter to the editor]. J Nucl Med 1987; 28: 1781-1782.
43. Meyer C M, Lecklitner M L, Logic JR, Balch CE, Bessey PQ, Tauxc WN. Technetium-99m sulfur colloid cutaneous lymphoscintigraphy in the management of truncal melanoma. Radiology 1979; 131: 205-209.
44. Strand S-E, Bergqvist L. Radiolabeled colloids and macromolecules in lymphatic system. Crit Rev Ther Drug Carrier Sys 1989; 6:211-238.
45. Kaplan WD, Piez CW, Gelman RS, et al. Clinical comparison of two radiocolloids for internal mammary lymphoscintigraphy. J Nucl Med 1985; 26: 1382-1385.
46. Goldfarb LR, Alazraki NP, Eshima D, Eshima LA, Herda SC, Halkar RK. Lymphoscintigraphic identification of sentinel lymph nodes: clinical evaluation of 0.22 μm filtration of Tc-99m sulfur colloid. Radiology 1998; 208: 505-509.
47. Taylor A, Murray D, Herda S, Vansant J, Alazraki N. Dynamic lymphoscintigraphy to identify the sentinel and satellite nodes. Clin Nucl Med 1996; 21: 755-758.
48. Wong JH, Terada K, Ko P, Coel MN. Lack of effect of particle size on the identification of the sentinel node in cutaneous malignancies. Ann Surg Oncol 1998; 5: 77-80.
49. Pijpers R, Collet GI, Meijer S, Hoekstra OS. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 1995; 22: 1238-1241.
50. Wanebo HJ, Harpole D, Teates CD. Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk. Cancer 1985; 55: 1403-1413.